Related Experiment Video

Updated: Jul 13, 2025

Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4
12:09

Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4

Published on: December 31, 2013

10.2K

Molecular pharmacology of the onco-TRP channel TRPV6

Arthur Neuberger1, Alexander I Sobolevsky1

  • 1Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY, USA.

Channels (Austin, Tex.)
|October 15, 2023
PubMed

Insights

Inhibitors targeting TRPV6 (Transient Receptor Potential Vanilloid 6), a key calcium channel, are crucial for treating diseases like cancer. Recent structural pharmacology reveals molecular mechanisms for inhibiting this oncochannel with various compounds.

Area of Science:

  • Molecular pharmacology
  • Calcium channel biology
  • Oncochannel research

Background:

  • Transient Receptor Potential Vanilloid 6 (TRPV6) is the primary calcium uptake channel in the intestine.
  • TRPV6 dysregulation disrupts calcium homeostasis, contributing to diseases, notably various cancers.
  • There is a significant need for effective TRPV6 inhibitors.

Purpose of the Study:

  • To review recent advancements in the structural pharmacology of TRPV6 inhibitors.
  • To elucidate the molecular mechanisms underlying TRPV6 inhibition.
  • To provide an overview of diverse small molecule inhibitors.

Main Methods:

  • Review of recent structural pharmacology studies.
  • Analysis of molecular mechanisms of inhibition.
  • Categorization of small molecule inhibitors (synthetic, natural, prospective, approved drugs).

Main Results:

  • Advances in structural pharmacology have revealed how small molecules inhibit TRPV6.
  • Diverse compounds, including plant-derived and synthetic molecules, demonstrate inhibitory potential.
  • Understanding these mechanisms paves the way for developing novel therapeutic agents.

Conclusions:

  • Structural insights are key to understanding TRPV6 inhibition.
  • A range of small molecules can target TRPV6, offering therapeutic possibilities.
  • Further research into these inhibitors could lead to new treatments for TRPV6-associated diseases.
Keywords:
TRP channelsTRPV6cancercryo-EMinhibitorstructural biology

More Related Videos

Controllable Ion Channel Expression through Inducible Transient Transfection10:00

Controllable Ion Channel Expression through Inducible Transient Transfection

Published on: February 17, 2017

9.4K
A Simple and Inexpensive Method for Determining Cold Sensitivity and Adaptation in Mice08:35

A Simple and Inexpensive Method for Determining Cold Sensitivity and Adaptation in Mice

Published on: March 17, 2015

14.9K

Related Concept Videos

Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
6.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Mechanically-gated Ion Channels01:12

Mechanically-gated Ion Channels

Mechanically-gated ion channels are proteins found in eukaryotic and prokaryotic cell membranes that open in response to mechanical stress. Tension, compression, swelling, and shear stress can alter the conformation of the protein, opening a transmembrane channel that allows the passage of ions for signal transmission. In eukaryotes, mechanically-gated channels are distributed in several regions like the neurons, lungs, skin, bladder, and heart, where they play critical roles in numerous...
6.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
13.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K